Literature DB >> 17000291

The effect of diabetes mellitus on patients undergoing coronary surgery: a risk-adjusted analysis.

Chanaka Rajakaruna1, Chris A Rogers, Chinthaki Suranimala, Gianni D Angelini, Raimondo Ascione.   

Abstract

BACKGROUND: Surgical case-mix is seriously worsening, and the results of surgical revascularization on high-risk cohorts should be continuously evaluated. This study investigates the influence of diabetes mellitus on the short and midterm outcome in the modern era of coronary surgery. METHODS AND
RESULTS: Patients who underwent first-time coronary artery bypass grafting from April 1996 to October 2003 were classified into diabetic and nondiabetic groups. Data were prospectively collected and retrospectively analyzed. A total of 5259 patients were studied, and of these 877 (17%) were diabetic. Patients with diabetes were more likely to be female, have a higher body mass index, be in an advanced New York Heart Association class and Canadian Cardiovascular Society class, have a history of congestive heart failure, have a poor ejection fraction, renal failure, and more extensive coronary artery disease than the nondiabetic group (P < .001 for all). In-hospital mortality was 2.2% and 1% for diabetic and nondiabetic patients, respectively; however, diabetes was not found to be an independent risk factor for in-hospital mortality (odds ratio = 1.63; 95% confidence interval 0.92-2.88; P = .089). Postoperative complications were comparable in the two groups, with only renal, neurologic, and gastrointestinal complications significantly associated with diabetes (all P < or = .05). There was no association between diabetes mellitus and postoperative infective complications. Diabetes remained an independent predictor of 5-year mortality (hazard ratio 1.55; 95% confidence interval 1.22-1.96; P < .001) and of lower 5-year cardiac-related event-free survival.
CONCLUSION: Despite a worsening cohort, diabetic patients could be surgically revascularized with low morbidity and mortality, comparable with control patients. The negative effect of diabetes mellitus on the longer-term mortality and morbidity remains a problem.

Entities:  

Mesh:

Year:  2006        PMID: 17000291     DOI: 10.1016/j.jtcvs.2006.05.056

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  11 in total

Review 1.  Optimal use of arterial grafts during current coronary artery bypass surgery.

Authors:  Suzuki Tomoaki
Journal:  Surg Today       Date:  2017-07-13       Impact factor: 2.549

2.  The current status of multi-arterial off-pump coronary artery bypass grafting.

Authors:  Suzuki Tomoaki; Asai Tohru
Journal:  Surg Today       Date:  2015-02-13       Impact factor: 2.549

3.  Preoperative hemoglobin A1c predicts atrial fibrillation after off-pump coronary bypass surgery.

Authors:  Takeshi Kinoshita; Tohru Asai; Tomoaki Suzuki; Atsushi Kambara; Keiji Matsubayashi
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

Review 4.  Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis.

Authors:  Bethany B Barone; Hsin-Chieh Yeh; Claire F Snyder; Kimberly S Peairs; Kelly B Stein; Rachel L Derr; Antonio C Wolff; Frederick L Brancati
Journal:  Diabetes Care       Date:  2010-04       Impact factor: 19.112

5.  The effect of diabetes mellitus on short term mortality and morbidity after isolated coronary artery bypass grafting surgery.

Authors:  Vahideh Koochemeshki; Hamid Reza Salmanzadeh; Hojjat Sayyadi; Morteza Amestejani; Shahyad Salehi Ardabili
Journal:  Int Cardiovasc Res J       Date:  2013-06-01

6.  Insulin infusion on postoperative complications of coronary artery bypass graft in patients with diabetes mellitus.

Authors:  Gholamreza Masoumi; Rasoul Frasatkhish; Hamid Bigdelian; Mohsen Ziyaefard; Ali Sadeghpour-Tabae; Mojtaba Mansouri; Alireza Jalali
Journal:  Res Cardiovasc Med       Date:  2014-04-01

7.  Gender Difference in the Long-Term Clinical Implications of New-Onset Atrial Fibrillation after Coronary Artery Bypass Grafting.

Authors:  Seung Hyun Lee; Hancheol Lee; Jin Kyu Park; Jae Sun Uhm; Jong Youn Kim; Hui Nam Pak; Moon Hyoung Lee; Ho Geun Yoon; Boyoung Joung
Journal:  Yonsei Med J       Date:  2017-11       Impact factor: 2.759

8.  Glycated hemoglobin HbA1c - a new risk marker for the outcome of cardiac surgery?

Authors:  Andrzej Biskupski; Szymon Waligórski; Bogdan Kowalik; Andrzej Żych; Piotr Sielicki; Oktawiusz Mirecki; Seweryn Grudniewicz; Mirosław Brykczyński
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-03-27

9.  The Effects of Preoperative Volume Replacement in Diabetic Patients Undergoing Coronary Artery Bypass Grafting Surgery: Protocol for a Randomized Controlled Trial (VeRDiCT Trial).

Authors:  Madeleine Clout; Tracy Harris; Chris Rogers; Lucy Culliford; Jodi Taylor; Gianni Angelini; Pradeep Narayan; Barnaby Reeves; James Hillier; Kate Ashton; Kunal Sarkar; Raimondo Ascione
Journal:  JMIR Res Protoc       Date:  2017-06-19

Review 10.  Does HbA1c Level Have Clinical Implications in Diabetic Patients Undergoing Coronary Artery Bypass Grafting? A Systematic Review and Meta-Analysis.

Authors:  Jia Zheng; Jing Cheng; Tong Wang; Qian Zhang; Xinhua Xiao
Journal:  Int J Endocrinol       Date:  2017-09-17       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.